Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
NCT ID: NCT06356129
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
850 participants
INTERVENTIONAL
2024-06-19
2029-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients
NCT03650933
Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT07269639
A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
NCT06035497
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
NCT06271057
Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
NCT02285062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Golcadomide + R-CHOP (Rituximab, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone)
Golcadomide
Specified dose on specified days
Rituximab
Specified dose on specified days
Cyclophosphamide
Specified dose on specified days
Doxorubicin
Specified dose on specified days
Vincristine
Specified dose on specified days
Prednisone
Specified dose on specified days
Placebo + R-CHOP
Placebo
Specified dose on specified days
Rituximab
Specified dose on specified days
Cyclophosphamide
Specified dose on specified days
Doxorubicin
Specified dose on specified days
Vincristine
Specified dose on specified days
Prednisone
Specified dose on specified days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Golcadomide
Specified dose on specified days
Placebo
Specified dose on specified days
Rituximab
Specified dose on specified days
Cyclophosphamide
Specified dose on specified days
Doxorubicin
Specified dose on specified days
Vincristine
Specified dose on specified days
Prednisone
Specified dose on specified days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
i) Diffuse large B-cell lymphoma (DLBCL), not otherwise specified \[including germinal center B-cell (GCB) and activated B-cell (ABC) types\]
ii) High-grade B-cell lymphoma, with MYC and BCL2 rearrangements (HGBL-MYC/BCL2 double-hit lymphomas)
iii) High-grade B-cell lymphoma, not otherwise specified
iv) T-cell/histiocyte/rich large B-cell lymphoma (THRLBCL)
v) Epstein-Barr virus + DLBCL
* International Prognostic Index (IPI) score 1 or 2 with lactate dehydrogenase (LDH) \> 1.3 x upper limit of normal (ULN) and/or bulky disease defined as single lesion of ≥ 7 cm OR IPI ≥ 3.
* Measurable disease defined by at least 1 fluorodeoxyglucose (FDG)-avid lesion for FDG-avid subtype and 1 bi-dimensionally measurable (\> 1.5 cm in longest diameter) disease by computed tomography (CT) or magnetic resonance imaging (MRI), as defined by the Lugano classification.
* Must have Ann Arbor Stage II-IV disease.
Exclusion Criteria
* Any other subtype of lymphoma. Cases of primary mediastinal (thymic) large B-cell lymphoma (PMBCL), primary cutaneous DLBCL-leg type, Grade 3b FL, indolent lymphoma transformed to large B-cell lymphoma (LBCL), Anaplastic lymphoma kinase (ALK) positive large B-cell lymphoma, primary effusion lymphoma, and Burkitt lymphoma.
* Documented or suspected central nervous system (CNS) involvement by lymphoma.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Celgene
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Bristol-Myers Squibb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USA Mitchell Cancer Institute
Mobile, Alabama, United States
Alaska Oncology and Hematology
Anchorage, Alaska, United States
Mayo Clinic in Arizona - Phoenix
Phoenix, Arizona, United States
Local Institution - 0342
San Francisco, California, United States
Florida Cancer Specialists - South
Fort Myers, Florida, United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Local Institution - 0415
Margate, Florida, United States
Mount Sinai Cancer Center
Miami Beach, Florida, United States
Sacred Heart Medical Oncology Group
Pensacola, Florida, United States
Florida Cancer Specialists - North
St. Petersburg, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Florida Cancer Specialists - East
West Palm Beach, Florida, United States
Cleveland Clinic Florida
Weston, Florida, United States
Emory University School of Medicine- Grady Campus
Atlanta, Georgia, United States
Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Local Institution - 0182
Chicago, Illinois, United States
Orchard Healthcare Research Inc.
Skokie, Illinois, United States
Mission Cancer + Blood
Waukee, Iowa, United States
The University of Kansas Cancer Center - Westwood
Westwood, Kansas, United States
Local Institution - 0436
Edgewood, Kentucky, United States
Mary Bird Perkins Cancer Center Baton Rouge
Baton Rouge, Louisiana, United States
University of Michigan
Ann Arbor, Michigan, United States
Allina Health Cancer Institute - Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
Mayo Clinic in Rochester, Minnesota
Rochester, Minnesota, United States
Local Institution - 0437
Kansas City, Missouri, United States
Cancer Care Specialists
Reno, Nevada, United States
Astera Cancer Care
East Brunswick, New Jersey, United States
Local Institution - 0480
Hackensack, New Jersey, United States
Atlantic Health System Morristown Medical Center
Morristown, New Jersey, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Local Institution - 0190
Buffalo, New York, United States
Hematology-Oncology Associates of Central New York, PC
East Syracuse, New York, United States
Local Institution - 0484
New York, New York, United States
Local Institution - 0369
New York, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Local Institution - 0174
Chapel Hill, North Carolina, United States
Local Institution - 0066
Massillon, Ohio, United States
Local Institution - 0450
Tulsa, Oklahoma, United States
Oregon Health and Science University
Portland, Oregon, United States
Local Institution - 0009
Pittsburgh, Pennsylvania, United States
WellSpan Oncology Research
York, Pennsylvania, United States
Brooke Army Medical Center
Fort Sam Houston, Texas, United States
Local Institution - 0516
Houston, Texas, United States
Memorial Hermann Hospital - Texas Medical Center
Houston, Texas, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Virginia Commonwealth University (VCU) Medical Center
Richmond, Virginia, United States
Local Institution - 0465
Tacoma, Washington, United States
Local Institution - 0113
Buenos Aires, Buenos Aires F.D., Argentina
Local Institution - 0421
Buenos Aires, Buenos Aires F.D., Argentina
Local Institution - 0112
Buenos Aires, , Argentina
Local Institution - 0119
Buenos Aires, , Argentina
Local Institution - 0136
Buenos Aires, , Argentina
Local Institution - 0111
Córdoba, , Argentina
Local Institution - 0357
Gosford, New South Wales, Australia
Local Institution - 0361
Sydney, New South Wales, Australia
Local Institution - 0358
Westmead, New South Wales, Australia
Local Institution - 0363
Tiwi, Northern Territory, Australia
Local Institution - 0356
Birtinya, Queensland, Australia
Local Institution - 0360
Southport, Queensland, Australia
Local Institution - 0365
Frankston, Victoria, Australia
Local Institution - 0362
Heidelberg, Victoria, Australia
Local Institution - 0359
St Albans, Victoria, Australia
Local Institution - 0364
Warrnambool, Victoria, Australia
Local Institution - 0385
Wels, Upper Austria, Austria
Local Institution - 0387
Linz, , Austria
Local Institution - 0386
Vienna, , Austria
Núcleo de Oncologia e Hematologia do Ceará
Fortaleza, Ceará, Brazil
Hospital Brasilia
Lago Sul, Federal District, Brazil
Universidade Federal de Goias
Goiânia, Goiás, Brazil
Hospital Erasto Gaertner
Curitiba, Paraná, Brazil
CHN - Complexo Hospitalar de Niterói
Niterói, Rio de Janeiro, Brazil
Liga Norte Riograndense Contra o Câncer
Natal, Rio Grande do Norte, Brazil
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa
Porto Alegre, Rio Grande do Sul, Brazil
Clínica Supera
Chapecó, Santa Catarina, Brazil
Instituto Joinvilense de Hematologia e Oncologia
Joinville, Santa Catarina, Brazil
Fundação Pio XII - Hospital de Câncer de Barretos
Barretos, São Paulo, Brazil
Hospital Amaral Carvalho
Jaú, São Paulo, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto
São José do Rio Preto, São Paulo, Brazil
Hospital Alemao Oswaldo Cruz
São Paulo, São Paulo, Brazil
A. C. Camargo Cancer Center
São Paulo, São Paulo, Brazil
Hospital São Lucas de Copacabana
Rio de Janeiro, , Brazil
Hospital 9 De Julho
São Paulo, , Brazil
Instituto D'Or de Pesquisa e Ensino (IDOR)
São Paulo, , Brazil
Hospital das Clinicas FMUSP
São Paulo, , Brazil
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
São Paulo, , Brazil
University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD
Plovdiv, , Bulgaria
Local Institution - 0392
Sofia, , Bulgaria
UMHAT 'Sveti Ivan Rilsky'
Sofia, , Bulgaria
Local Institution - 0492
Edmonton, Alberta, Canada
Local Institution - 0091
Victoria, British Columbia, Canada
Local Institution - 0153
Montreal, Quebec, Canada
Local Institution - 0073
Montreal, Quebec, Canada
Local Institution - 0004
Sherbrooke, Quebec, Canada
Local Institution - 0164
Viña del Mar, Región de Valparaíso, Chile
Local Institution - 0109
Chile, Santiago Metropolitan, Chile
Local Institution - 0106
Santiago, Santiago Metropolitan, Chile
Local Institution - 0107
Santiago, Santiago Metropolitan, Chile
Local Institution - 0108
Santiago, Santiago Metropolitan, Chile
Local Institution - 0110
Santiago, Santiago Metropolitan, Chile
Local Institution - 0459
Santiago, Santiago Metropolitan, Chile
Peking University Third Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
Fujian Cancer Hospital
Fuzhou, Fujian, China
The First Affiliated hospital of Xiamen University
Xiamen, Fujian, China
Southern Medical University Nanfang Hospital
Guangzhou, Guangdong, China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Guangxi Medical University Affiliated Tumor Hospital
Nanning, Guangxi, China
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Tongji Hospital Tongji Medical,Science & Technology
Wuhan, Hubei, China
Hunan Cancer Hospital
Changsha, Hunan, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Jiangxi Provincial Cancer Hospital
Nanchang, Jiangxi, China
The First Hospital of Jilin University
Changchun, Jilin, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
The First Hospital of China Medical University
Shenyang, Liaoning, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Shandong Cancer Hospital
Jinan, Shandong, China
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Local Institution - 0289
Tianjin, Tianjin Municipality, China
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
Xinjiang Medical University Cancer Hospital - Urumqi
Ürümqi, Xinjiang, China
Local Institution - 0155
Ürümqi, Xinjiang, China
The first Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
The Second Affiliated hospital of Zhejiang University school of medicine
Hangzhou, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Fundacion Ctic Centro de Tratamiento E Investigacion Sobre Cancer Luis Carlos Sarmiento Angulo
Bogotá, Bogota D.C., Colombia
Instituto Nacional De Cancerologia
Bogota, Cundinamarca, Colombia
Local Institution - 0390
Zagreb, City of Zagreb, Croatia
Local Institution - 0440
Osijek, , Croatia
Fakultní nemocnice Brno Bohunice
Brno, Brno-město, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, Hradec Králové, Czechia
Fakultni nemocnice Olomouc
Olomouc, Olomoucký kraj, Czechia
Fakultni Nemocnice Plzen
Pilsen, Plzeň Region, Czechia
Fakultni nemocnice Kralovske Vinohrady
Prague, Praha 10, Czechia
Vseobecna fakultni nemocnice v Praze
Prague, , Czechia
Local Institution - 0285
Aarhus, Central Jutland, Denmark
Local Institution - 0284
Odense, Region Syddanmark, Denmark
Local Institution - 0281
Oulu, North Ostrobothnia, Finland
Local Institution - 0283
Kuopio, Northern Savonia, Finland
Local Institution - 0282
Turku, Southwest Finland, Finland
Local Institution - 0280
Helsinki, , Finland
Local Institution - 0083
Nice, Alpes-Maritimes, France
Local Institution - 0084
Strasbourg, Alsace, France
Local Institution - 0090
Bordeaux, Aquitaine, France
Local Institution - 0324
Pessac, Aquitaine, France
Local Institution - 0087
Marseille, Bouches-du-Rhône, France
Local Institution - 0292
Dijon, Côte-d'Or, France
Local Institution - 0486
Besançon, Doubs, France
Local Institution - 0332
Brest, Finistère, France
Local Institution - 0202
Lille, Hauts-de-France, France
Local Institution - 0335
Saint-Cloud, Hauts-de-Seine, France
Local Institution - 0079
Tours, Indre-et-Loire, France
Local Institution - 0223
La Tronche, Isère, France
Local Institution - 0323
Saint-Pierre, La Réunion, France
Local Institution - 0074
Montpellier, Languedoc-Roussillon, France
Local Institution - 0081
Lille, Nord, France
Local Institution - 0325
Nantes, Pays de la Loire Region, France
Local Institution - 0321
Saint Priest En Jarez, Pays de la Loire Region, France
Local Institution - 0089
Pierre-Bénite, Rhône, France
Local Institution - 0200
Créteil, Val-de-Marne, France
Local Institution - 0076
Villejuif, Val-de-Marne, France
Local Institution - 0306
Poitiers, Vienne, France
Local Institution - 0244
Bayonne, , France
Local Institution - 0315
Caen, , France
Local Institution - 0077
Paris, , France
Local Institution - 0511
Ulm, Baden-Wurttemberg, Germany
Local Institution - 0383
Augsburg, Bavaria, Germany
Local Institution - 0512
Bayreuth, Bavaria, Germany
Local Institution - 0505
Erlangen, Bavaria, Germany
Local Institution - 0507
Langen, Hesse, Germany
Local Institution - 0513
Hanover, Lower Saxony, Germany
Local Institution - 0384
Koblenz, Rhineland-Palatinate, Germany
Local Institution - 0504
Halle, Saxony-Anhalt, Germany
Local Institution - 0506
Lübeck, Schleswig-Holstein, Germany
Local Institution - 0508
Berlin, , Germany
Local Institution - 0503
Cottbus, , Germany
Local Institution - 0510
Dresden, , Germany
Local Institution - 0370
Essen, , Germany
Local Institution - 0398
Alexandroupoli, Anatolikí Makedonía Kai Thráki, Greece
Local Institution - 0399
Athens, Attikí, Greece
Local Institution - 0396
Athens, Attikí, Greece
Local Institution - 0397
Chaïdári, Attikí, Greece
Local Institution - 0395
Ioannina, Ípeiros, Greece
Debreceni Egyetem Klinikai Kozpont
Debrecen, Hajdú-Bihar, Hungary
Somogy Vármegyei Kaposi Mór Oktató Kórház
Kaposvár, Somogy County, Hungary
Szabolcs Szatmár Bereg Vármegyei Oktatókórház
Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary
Markusovszky Egyetemi Oktatokorhaz
Szombathely, Vas County, Hungary
Semmelweis Egyetem
Budapest, , Hungary
Országos Onkológiai Intézet
Budapest, , Hungary
Local Institution - 0429
Srinagar, Jammu and Kashmir, India
KLES Dr. Prabhakar Kore Hospital & M.R.C
Belagavi, Karnataka, India
Aster Medcity
Kochi, Kerala, India
Tata Memorial Hospital
Mumbai, Maharashtra, India
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
Rajiv Gandhi Cancer Institute And Research Centre
New Delhi, National Capital Territory of Delhi, India
Narayana Superspecialty Hospital
Howrah, West Bengal, India
Tata Medical Center
New Town, West Bengal, India
Local Institution - 0495
Ravenna, Emilia-Romagna, Italy
Local Institution - 0493
Rome, Lazio, Italy
Az. Osp. Ospedali Riuniti VILLA SOFIA-CERVELLO
Palermo, Sicily, Italy
Local Institution - 0496
Novara, , Italy
Local Institution - 0276
Anjo, Aichi-ken, Japan
Local Institution - 0371
Nagoya, Aichi-ken, Japan
Local Institution - 0168
Kashiwa, Chiba, Japan
Local Institution - 0475
Eiheiji-cho,Yoshida-gun, Fukui, Japan
Local Institution - 0271
Ōgaki, Gifu, Japan
Local Institution - 0368
Sapporo, Hokkaido, Japan
Local Institution - 0327
Sapporo, Hokkaido, Japan
Local Institution - 0273
Amagasaki, Hyōgo, Japan
Local Institution - 0328
Himeji, Hyōgo, Japan
Local Institution - 0270
Kanazawa, Ishikawa-ken, Japan
Local Institution - 0343
Morioka, Iwate, Japan
Local Institution - 0170
Isehara, Kanagawa, Japan
Local Institution - 0333
Yokohama, Kanagawa, Japan
Local Institution - 0320
Sendai, Miyagi, Japan
Local Institution - 0166
Sakai, Osaka, Japan
Local Institution - 0269
Hidaka, Saitama, Japan
Local Institution - 0288
Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
Local Institution - 0350
Bunkyo-ku, Tokyo, Japan
Local Institution - 0268
Itabashiku, Tokyo, Japan
Local Institution - 0331
Chūō, Yamanashi, Japan
Local Institution - 0348
Fukuoka, , Japan
Local Institution - 0319
Fukuoka, , Japan
Local Institution - 0313
Fukuoka, , Japan
Local Institution - 0272
Hiroshima, , Japan
Local Institution - 0171
Kumamoto, , Japan
Local Institution - 0215
Kyoto, , Japan
Local Institution - 0329
Okayama, , Japan
Local Institution - 0322
Osaka, , Japan
Local Institution - 0347
Osaka, , Japan
Local Institution - 0167
Yamagata, , Japan
Local Institution - 0453
Lembah Pantai, Kuala Lumpur, Malaysia
Local Institution - 0432
George Town, Pulau Pinang, Malaysia
Local Institution - 0431
Kuching, Sarawak, Malaysia
Local Institution - 0449
Ampang, Selangor, Malaysia
Health Pharma Professional Research S.A. de C.V:
Mexico City, DIF, Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, DIF, Mexico
Local Institution - 0448
Guadalajara, Jalisco, Mexico
Local Institution - 0128
Mexico City, Mexico City, Mexico
Local Institution - 0126
Mexico City, Mexico City, Mexico
Centro de Investigacion Clinica Chapultepec
Morelia, Michoacán, Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, Mexico
Centro de Investigacion Clinica de Oaxaca
Oaxaca City, Oaxaca, Mexico
Local Institution - 0444
Hermosillo, Sonora, Mexico
Local Institution - 0463
Hermosillo, Sonora, Mexico
Local Institution - 0123
Huixquilucan, , Mexico
Unidad Médica Onco-hematológica
Puebla City, , Mexico
Local Institution - 0500
Leiden, South Holland, Netherlands
Local Institution - 0499
Groningen, , Netherlands
Local Institution - 0367
Dunedin, Otago, New Zealand
Local Institution - 0366
Hamilton, Waikato Region, New Zealand
Local Institution - 0462
Auckland, , New Zealand
Local Institution - 0391
Oslo, , Norway
Aidport
Skórzewo, Greater Poland Voivodeship, Poland
Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Pratia MCM Krakow
Krakow, Lesser Poland Voivodeship, Poland
Centrum Onkologii Ziemi Lubelskiej
Lublin, Lublin Voivodeship, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie
Warsaw, Masovian Voivodeship, Poland
Local Institution - 0330
Katowice, Silesian Voivodeship, Poland
Local Institution - 0286
Lisbon, , Portugal
Local Institution - 0098
Porto, , Portugal
Pan American Center for Oncology Trials - Ciudadela
San Juan, , Puerto Rico
Fundeni Clinical Institute
Bucharest, București, Romania
Local Institution - 0375
Bucharest, București, Romania
Spital Clinic Judetean de Urgenta Tg.Mures
Tg.Mures, Mureș County, Romania
Sc Onco Card Srl
Brasov, , Romania
Affidea Fundeni
Bucharest, , Romania
Spitalul Clinic Colțea
Bucharest, , Romania
Spitalul Clinic Colțea
Bucharest, , Romania
Spitalul Universitar de Urgență București
Bucharest, , Romania
Institutul Oncologic Cluj
Cluj-Napoca, , Romania
Institutul Regional de Oncologie
Iași, , Romania
Spitalul Clinic Județean de Urgență Sibiu
Sibiu, , Romania
Local Institution - 0439
Dammam, Eastern Province, Saudi Arabia
Local Institution - 0445
Riyadh, Riyadh Region, Saudi Arabia
Local Institution - 0438
Jeddah, , Saudi Arabia
Local Institution - 0416
Riyadh, , Saudi Arabia
Local Institution - 0427
Singapore, Central Singapore, Singapore
Local Institution - 0355
Banská Bystrica, Banská Bystrica Region, Slovakia
Local Institution - 0204
Bratislava, , Slovakia
Local Institution - 0149
Goyang-si, Kyǒnggi-do, South Korea
Local Institution - 0117
Seongnam, Kyǒnggi-do, South Korea
Local Institution - 0456
Seongnam, Kyǒnggi-do, South Korea
Local Institution - 0233
Suwon, Kyǒnggi-do, South Korea
Local Institution - 0115
Busan, Pusan-Kwangyǒkshi, South Korea
Local Institution - 0114
Busan, Pusan-Kwangyǒkshi, South Korea
Local Institution - 0131
Busan, Pusan-Kwangyǒkshi, South Korea
Local Institution - 0143
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0069
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0100
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0068
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0070
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0442
Daegu, Taegu-Kwangyǒkshi, South Korea
Local Institution - 0116
Deagu, Taegu-Kwangyǒkshi, South Korea
Local Institution - 0441
Deagu, Taegu-Kwangyǒkshi, South Korea
Local Institution - 0455
Seongnam, , South Korea
Local Institution - 0118
Seoul, , South Korea
Local Institution - 0412
A Coruña, A Coruña [La Coruña], Spain
Local Institution - 0491
Badalona, Barcelona [Barcelona], Spain
Local Institution - 0071
L'Hospitalet Del Llobregat, Barcelona [Barcelona], Spain
Local Institution - 0389
Barakaldo, Bizkaia, Spain
Local Institution - 0172
Santa Cruz de Tenerife, Canary Islands, Spain
Local Institution - 0314
Donostia / San Sebastian, Gipuzkoa, Spain
Local Institution - 0096
Majadahonda, Madrid, Comunidad de, Spain
Local Institution - 0409
El Palmar, Murcia, Murcia, Región de, Spain
Local Institution - 0092
Málaga, Málaga, Spain
Local Institution - 0095
Cáceres, , Spain
Local Institution - 0072
Madrid, , Spain
Local Institution - 0490
Madrid, , Spain
Local Institution - 0488
Madrid, , Spain
Local Institution - 0093
Salamanca, , Spain
Local Institution - 0489
Seville, , Spain
Local Institution - 0279
Lund, Skåne Län [se-12], Sweden
Local Institution - 0487
Solna, Stockholms Län [se-01], Sweden
Local Institution - 0277
Uppsala, Uppsala Län [se-03], Sweden
Local Institution - 0278
Linköping, Östergötlands Län [se-05], Sweden
Chang Gung Memorial Hospital- Chiayi
Chiayi City, Chiayi, Taiwan
Chi Mei Medical Center
Tainan, Tainan, Taiwan
Chang Gung Memorial Hospital at Kaohsiung
Kaohsiung City, , Taiwan
China Medical University Hospital
Taichung, , Taiwan
Taichung Veterans General Hospital
Taichung, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Taipei Veterans General Hospital
Taipei, , Taiwan
Koo Foundation Sun Yat-Sen Cancer Center
Taipei, , Taiwan
Chang Gung Medical Foundation-Linkou Branch
Taoyuan District, , Taiwan
Local Institution - 0434
Bangkok, Bangkok, Thailand
Ramathibodi Hospital
Bangkok, Bangkok, Thailand
Faculty of Medicine Siriraj Hospital
Bangkok, Bangkok, Thailand
Local Institution - 0428
Chiang Mai, , Thailand
Ankara University Health Practice and Research Hospitals
Ankara, , Turkey (Türkiye)
Gazi University Health Research and Application Center Gazi Hospital
Ankara, , Turkey (Türkiye)
Local Institution - 0422
Ankara, , Turkey (Türkiye)
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi
Ankara, , Turkey (Türkiye)
Ege Universitesi Hastanesi
Izmir, , Turkey (Türkiye)
VM Medical Park Mersin Hastanesi
Mersin, , Turkey (Türkiye)
Ondokuz Mayıs Universitesi
Samsun, , Turkey (Türkiye)
Karadeniz Teknik Universitesi Tip Fakultesi
Trabzon, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
Role: CONTACT
First line of the email MUST contain the NCT# and Site #.
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anita Mazloom, Site 0014
Role: primary
Steven Liu, Site 0477
Role: primary
Javier Munoz, Site 0452
Role: primary
Site 0342
Role: primary
Syed Zafar, Site 0497
Role: primary
Muhamad Alhaj Moustafa, Site 0287
Role: primary
Jacqueline Barrientos, Site 0045
Role: primary
Alex Brown, Site 0012
Role: primary
Susmitha Apuri, Site 0502
Role: primary
Bijal Shah, Site 0414
Role: primary
Shachar Peles, Site 0192
Role: primary
Chakra Chaulagain, Site 0485
Role: primary
Carlos Lopez, Site 0515
Role: primary
Carlos Lopez, Site 0303
Role: primary
Site 0182
Role: primary
Ira Oliff, Site 0048
Role: primary
Tara Graff, Site 0461
Role: primary
Marc Hoffmann, Site 0031
Role: primary
Site 0436
Role: primary
Victor Lin, Site 0408
Role: primary
Jonathan Weiss, Site 0478
Role: primary
Fiona He, Site 0067
Role: primary
Yucai Wang, Site 0203
Role: primary
Site 0437
Role: primary
Santhosh Ambika, Site 0466
Role: primary
Bruno Fang, Site 0498
Role: primary
Site 0480
Role: primary
Charles Farber, Site 0049
Role: primary
Matthew Matasar, Site 0175
Role: primary
Site 0190
Role: primary
Tarek Sousou, Site 0451
Role: primary
Site 0484
Role: primary
Site 0369
Role: primary
Suchitra Sundaram, Site 0176
Role: primary
Site 0174
Role: primary
Site 0066
Role: primary
Craig Okada, Site 0179
Role: primary
Ikechukwu Akunyili, Site 0419
Role: primary
Michael osswald, Site 0435
Role: primary
Site 0516
Role: primary
Adan Rios, Site 0424
Role: primary
Jason Westin, Site 0046
Role: primary
Bruce Hough, Site 0293
Role: primary
Site 0421
Role: primary
Site 0386
Role: primary
José Rocha, Site 0255
Role: primary
Andresa Melo, Site 0297
Role: primary
Renato Sampaio Tavares, Site 0256
Role: primary
João Farias, Site 0302
Role: primary
Jacques Kaufman, Site 0296
Role: primary
Carolina Villarim, Site 0304
Role: primary
Marcelo Capra, Site 0253
Role: primary
Cristiano Vendrame, Site 0246
Role: primary
Marcelo Lacerda, Site 0247
Role: primary
Mariana Bianchi Carneiro, Site 0250
Role: primary
Marcia Higashi, Site 0249
Role: primary
Mariana Buka, Site 0301
Role: primary
Andre Abdo, Site 0248
Role: primary
Jayr Schmidt Filho, Site 0316
Role: primary
Ruddy Dalfeor, Site 0298
Role: primary
Vinicius de Molla, Site 0294
Role: primary
Abel Costa, Site 0252
Role: primary
Juliana Pereira, Site 0317
Role: primary
Guilherme Perini, Site 0251
Role: primary
Vasko Graklanov, Site 0393
Role: primary
Site 0392
Role: primary
Atanas Radinoff, Site 0394
Role: primary
Hongmei Jing, Site 0195
Role: primary
Xiaoqiong Tang, Site 0236
Role: primary
YING XIANG, Site 0196
Role: primary
Yu Yang, Site 0274
Role: primary
bing xu, Site 0157
Role: primary
Xiaolei Wei, Site 0133
Role: primary
Huiqiang Huang, Site 0240
Role: primary
Hong Cen, Site 0338
Role: primary
Qingyuan Zhang, Site 0239
Role: primary
Keshu Zhou, Site 0238
Role: primary
Liling Zhang, Site 0346
Role: primary
Xiaoxi zhou, Site 0214
Role: primary
Yajun Li, Site 0275
Role: primary
Zhengming Jin, Site 0156
Role: primary
Fei Li, Site 0237
Role: primary
Yan Huang, Site 0241
Role: primary
Ou Bai, Site 0291
Role: primary
Wei Yang, Site 0334
Role: primary
Xiaojing Yan, Site 0169
Role: primary
Ming Hou, Site 0242
Role: primary
Zengjun Li, Site 0344
Role: primary
Weili Zhao, Site 0132
Role: primary
Rong Tao, Site 0339
Role: primary
Jia Wei, Site 0234
Role: primary
Liqun Zou, Site 0141
Role: primary
Shiyong Zhou, Site 0470
Role: primary
Shujuan Wen, Site 0467
Role: primary
Hongyan Tong, Site 0197
Role: primary
Wenbin Qian, Site 0483
Role: primary
Songfu Jiang, Site 0457
Role: primary
Virginia Abello Polo, Site 0129
Role: primary
Juan Alejandro Ospina Idarraga, Site 0130
Role: primary
Michael Doubek, Site 0105
Role: primary
David Belada, Site 0104
Role: primary
VÍT PROCHÁZKA, Site 0102
Role: primary
Katerina Steinerova, Site 0120
Role: primary
Heidi Mocikova, Site 0103
Role: primary
Marek Trneny, Site 0243
Role: primary
Site 0324
Role: primary
Site 0292
Role: primary
Site 0508
Role: primary
Arpad Illes, Site 0266
Role: primary
Peter Rajnics, Site 0162
Role: primary
Laszlo Rejto, Site 0353
Role: primary
Mark Plander, Site 0161
Role: primary
ZSOLT GYORGY Nagy, Site 0163
Role: primary
Andras Masszi, Site 0160
Role: primary
Rohan Bhise, Site 0411
Role: primary
Arun Warrier, Site 0430
Role: primary
Bhausaheb Bagal, Site 0154
Role: primary
Deepam Pushpam, Site 0433
Role: primary
Narendra Agrawal, Site 0469
Role: primary
Vivek Agarwala, Site 0413
Role: primary
Arijit Nag, Site 0410
Role: primary
CATERINA PATTI, Site 0494
Role: primary
Site 0215
Role: primary
Juan Perez Zuñiga, Site 0122
Role: primary
Gladys Agreda Vásquez, Site 0121
Role: primary
Site 0128
Role: primary
Site 0126
Role: primary
Gregorio Campos Cabrera, Site 0127
Role: primary
David Gomez Almaguer, Site 0139
Role: primary
Gabriel Barragán Ibañez, Site 0125
Role: primary
Site 0123
Role: primary
WILFRIDO HERRERA, Site 0124
Role: primary
Site 0366
Role: primary
Michal Kwiatek, Site 0388
Role: primary
Lukasz Szukalski, Site 0336
Role: primary
Wojciech Jurczak, Site 0201
Role: primary
Wojciech Legiec, Site 0337
Role: primary
Joanna Romejko-Jarosinska, Site 0443
Role: primary
Site 0330
Role: primary
Maria Garcia-Pallas, Site 0372
Role: primary
Daniel Coriu, Site 0381
Role: primary
Ioan Macarie, Site 0417
Role: primary
Mihaela Lazaroiu, Site 0380
Role: primary
Mihaela Andreescu, Site 0374
Role: primary
Nicoleta Berbec, Site 0382
Role: primary
ANDREI COLITA, Site 0377
Role: primary
Horia Bumbea, Site 0378
Role: primary
Delia Dima, Site 0423
Role: primary
Catalin Danaila, Site 0379
Role: primary
ALINA CATANA, Site 0376
Role: primary
Site 0204
Role: primary
Site 0070
Role: primary
Site 0278
Role: primary
Cih-En Huang, Site 0142
Role: primary
Yin-Hsun Feng, Site 0146
Role: primary
Ming Chung Wang, Site 0159
Role: primary
Su-Peng Yeh, Site 0135
Role: primary
Po Wei Liao, Site 0145
Role: primary
Tai-Chung Huang, Site 0134
Role: primary
Chih-Cheng Chen, Site 0514
Role: primary
Tran-Der Tan, Site 0147
Role: primary
HSUAN-JEN SHIH, Site 0158
Role: primary
Pimjai niparuk, Site 0473
Role: primary
Archrob Khuhapinant, Site 0426
Role: primary
Muhit Ozcan, Site 0400
Role: primary
Munci Yagci, Site 0405
Role: primary
Site 0422
Role: primary
Mehmet Dal, Site 0401
Role: primary
Saydam Guray, Site 0406
Role: primary
ANIL TOMBAK, Site 0403
Role: primary
Mehmet Turgut, Site 0407
Role: primary
Mehmet Sonmez, Site 0402
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
BMS Clinical Trial Information
BMS Clinical Trial Patient Recruiting
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-510178-15
Identifier Type: REGISTRY
Identifier Source: secondary_id
U1111-1300-8493
Identifier Type: REGISTRY
Identifier Source: secondary_id
CA073-1020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.